Trial Profile
Efficacy and safety of budesonide/formoterol in patients with mild to moderate persistent asthma.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2011
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 28 Oct 2011 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan
- 29 Apr 2011 New trial record